Technical Analysis

Trading pick of the week: Buy Alembic Pharmaceuticals

Yoganand D | Updated on May 17, 2020 Published on May 17, 2020

A view of Alembic Pharmaceuticals's plant at Panelav, Gujarat

Investors with a medium-term horizon can buy the stock of Alembic Pharmaceuticals at current levels. The stock took support after recording a 52-week low at ₹25 in late March, following a medium-term downtrend from the key resistance level of ₹64.

Since late March, the stock has been in a medium-term uptrend. While trending up, it breached a key resistance at ₹47 and the 200-day moving average at the same level in late April.

Subsequently, this level turned into a key support and cushioned the stock in the past week.

On Friday, the stock jumped 9.2 per cent accompanied by extraordinary volume, and managed to close above a key resistance level of ₹51. This rally has strengthened the medium-term uptrend. Also, the stock is now trading well above its 50- and 200-day moving averages.

The daily relative strength index (RSI) has entered the bullish zone from the neutral region and the weekly RSI is on the brink of entering the bullish zone from the neutral region.

Both the daily and the weekly price rate of change indicators have entered the positive terrain from the negative terrain, implying buying interest.

The medium-term uptrend is intact and the outlook is bullish for Alembic.

It can continue to trend upwards and reach the price targets of ₹60 and ₹63 in the coming weeks.

Traders can buy the stock with a stop-loss at ₹47.

Published on May 17, 2020

A letter from the Editor


Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.